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ABSTRACT
The use of cell lines such as Madin-Darby Canine Kidney (MDCK) and African Green Monkey Kidney (Vero) cells in 
influenza vaccine production is much advocated presently as a safer alternative to chicken embryonated eggs. It is 
thus essential to understand the influenza virus replication patterns in these cell lines prior to utilizing them in vaccine 
production. The infectivity of avian influenza A virus (A/Chicken/Malaysia/5858/2004) H5N1 in MDCK and Vero cell 
lines was first assessed by comparing the cytopathic effect (CPE) caused by the virus infection. The viral loads in both 
of the infected media and cells were also compared. The results showed that both of the MDCK and Vero cells began to 
exhibit significant CPE (p<0.05) after 48 h post-infection (h p.i). The MDCK cell line was more susceptible to the virus 
infection compared to Vero cell line throughout the incubation period. A higher viral load was also detected in the host 
cells compared to their respective culturing media. Interestingly, after reaching its maximum titer at 48 h p.i, the viral 
load in MDCK cells declined meanwhile the viral load in Vero cells increased gradually and peaked at 120 h p.i. Overall, 
both cell lines support efficient H5N1 virus replication. While the peak viral loads measured in the two cell lines did 
not differ much, a more rapid replication was observed in the infected MDCK samples. The finding showed that MDCK 
cell line might serve as a more time-saving and cost-effective cell culture-based system compared to Vero cell line for 
influenza vaccine production.
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ABSTRAK
Penggunaan  kultur sel seperti sel ginjal kanin Madin-Darby (MDCK) dan monyet hijau Afrika (Vero) dalam penghasilan 
vaksin influenza adalah lebih selamat berbanding telur ayam berembrio yang disarankan pada masa ini. Maka, adalah 
penting untuk kita memahami corak replikasi virus influenza dalam sel-sel tersebut sebelum digunakan dalam penghasilan 
vaksin. Keboleh-jangkitan virus influenza jenis H5N1 (A/Chicken/Malaysia/5858/2004) dalam sel MDCK dan Vero dinilai 
dengan membandingkan kesan sitopatik (CPE) yang diakibatkan oleh jangkitan virus influenza. Titer virus dalam media 
dan sel terjangkit turut dibandingkan. Hasil kajian menunjukkan kedua-dua sel MDCK dan Vero mula mempamerkan CPE 
yang signifikan (p < 0.05) selepas 48 jam pasca-infeksi (h p.i). Sel MDCK adalah lebih rentan kepada jangkitan virus 
sepanjang tempoh eraman virus berbanding dengan sel Vero. Titer virus yang lebih tinggi diperoleh dalam sel perumah 
terjangkit berbanding dengan media kultur. Selepas mencapai titer maksimum pada 48 h p.i, titer virus dalam sel MDCK 
menurun manakala titer virus dalam sel Vero kekal meningkat secara perlahan dan memuncak pada 120 h p.i. Secara 
keseluruhan, kedua-dua sel perumah didapati mampu menyokong replikasi virus H5N1 dengan cekap. Meskipun titer 
virus maksimum yang dicapai antara kedua-dua sel perumah tidak berbeza, replikasi yang lebih pantas diperhatikan 
dalam sel MDCK. Hal ini mencadangkan penggunaan sel MDCK dalam penghasilan vaksin influenza adalah lebih jimat 
daripada segi masa dan kos berbanding dengan sel Vero.
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INTRODUCTION
Avian influenza A virus (AIV) is associated with yearly 
epidemics as well as sporadic pandemics (Sonnberg et 
al. 2013). Since the first recorded direct bird-to-human 
transmission of highly pathogenic avian influenza (HPAI) 
virus H5N1 in Hong Kong in 1997, the virus has spread 
to countries in Asia, Middle East, Africa and Europe. The 
virus causes death and illness in domestic and migratory 
birds, as well as vulnerable human beings (Subbarao & 
Matsuoka 2013). 
 Information on the growth of influenza virus in cell 
lines provides insights in understanding the patterns 
of virus replication. This is particularly crucial for the 
development of influenza vaccine (Abdoli et al. 2013; 
Wanasawaeng et al. 2009). Knowledge on the AIV 
replication and subsequently its host response are of utmost 
importance in developing an appropriate intervention 
against the virus (Matsuoka et al. 2013).  
 Today, chicken-embryonated-egg (CEG) is a system 
of choice for large scale production of influenza vaccine. 
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However, this system has several downfalls. Besides 
being labor-intensive, it is also prone to microbiological 
contaminants (Pan et al. 2013; Youil et al. 2004). Moreover, 
CEG is likely to be in short supply in the event of an 
influenza pandemic considering most chickens will be 
culled to curb the spread of the virus (Murakami et al. 
2008). Hence, the use of cell culture in influenza vaccine 
production is gradually gaining momentum. The egg-free 
system is known to support a rapid and larger scale of 
vaccine production (Murakami et al. 2012).
 The development of cell culture system for virus 
propagation has brought to major advances in virus vaccine 
production. Till date, the frequently used cell lines for 
influenza virus propagation include MDCK and Vero cells 
(Donis 2014). MDCK-derived influenza vaccine has shown 
promising protection in mouse model and its efficacy is 
antigenically equivalent to egg-derived influenza vaccines 
(Nerome et al. 1999) whilst the immunogenicity of Vero 
cell-derived influenza virus vaccine was comparable to 
that of the egg-derived vaccine in the context of humoral 
and cellular responses (Brühl et al. 2000). These findings 
substantiate that MDCK and Vero are ideal cell lines for cell 
culture-based influenza vaccine development.
 A thorough comparison of virus growth in cell lines 
might help to develop an optimized vaccine production 
strategy, as well as to assess quality differences concerning 
the virus strains and antigen produced (Genzel et al. 2010). 
In this study, a Malaysian isolate of HPAI H5N1 (A/chicken/
Malaysia/5858/2004) virus was used (Balasubramaniam 
et al. 2011). The AIV H5N1 replication in MDCK and Vero 
cells was compared by measuring the virus CPE in terms 
of percentage of cell death and viral load in both of the 
infected media and cells at designated time points. 
MATERIALS AND METHODS
CELLS AND VIRUS
MDCK and Vero cells were obtained from American 
Type Culture Collection (ATCC) and were maintained 
in Roswell Park Memorial Institute medium (RPMI-
1640, Gibco, Karlsruhe, Germany) supplemented with 
10% (v/v) fetal bovine serum (FBS, Gibco, Karlsruhe, 
Germany) and 100 μg/mL ampicillin. The cells were grown 
at 37°C in a 5% CO2 incubator. AIV H5N1 isolate (A/
chicken/5858/2004/Malaysia) was propagated as described 
in Balasubramaniam et al. (2011). A serial dilution of the 
virus (10-1 to 10-8) was done in RPMI-1640 medium.
MEASUREMENT OF VIRUS INFECTIVITY
50% tissue culture infectious dose (TCID50) of the 
AIV H5N1 was determined in MDCK and Vero cells, as 
described previously (Hamilton et al. 2011) with minor 
modifications. In addition, plaque assay was conducted to 
calculate the multiplicity of infection (MOI) of the virus. 
Briefly, 200 μL of each virus dilution (10-1 to 10-8) was 
inoculated into confluent cells and incubated for 1 h. The 
plates were shaken gently every 15 min. The media was 
then discarded, washed and replaced with an agar overlay 
(0.4% (w/v) agarose in RPMI-1640 media). On the fifth 
day, the cells were fixed with 4% (v/v) formaldehyde for 
1 h. The formaldehyde was then aspirated out and the agar 
overlay was removed. The cells were stained with 0.5% 
(w/v) crystal violet for 5 min before plaque visualization 
and counting. Uninfected cells were prepared as negative 
control.
ASSESSMENT OF CPE PERCENTAGE
1 × 106 MDCK and Vero cells were grown in T-25 flasks until 
confluency. The cells were then transfected with 500 μL 
of AIV H5N1 at MOI 0.1 and incubated for 1 h. The media 
was then discarded, washed and replaced with new media. 
The cells were further incubated for 0, 4, 8, 12, 24, 48, 72, 
96 and 120 h p.i. Uninfected cells were prepared along as 
the negative control. At each time point, CPE were assessed 
by calculating cell death using hemocytometer and 0.4% 
(w/v) trypan blue staining method. 
VIRUS RNA ISOLATION
At each time point (0-120 h p.i), the infected culturing 
media and cell were isolated separately. Total RNA 
extraction from the samples was carried out by using Tri-
RNA reagent (Favorgen, Pingtung, Taiwan) following the 
manufacturer’s instructions. About 90 ng of total RNA was 
used to generate cDNA using a cDNA synthesis kit (PCR 
Biosystems, London, UK). 
REAL TIME PCR
Real time PCR was carried out using the 2× qPCRBIO 
SyGreen Mix Hi-ROX (PCR Biosystems, London, UK) 
according to the manufacturer’s instructions. For viral 
detection, forward primer (5’- AGA ATT CAG TCT TCT 
AAC CGA GGT CGA AAC GCC TAC CAG AAA CGA 
A -3’) and reverse primer (5’- AGT CGA CCT CCA 
ATT CTA TGT TGA CAA AAT G -3’) were used for the 
amplification of AIV H5N1 Matrix 2 (M2) gene. A 10-fold 
serial dilution of known concentration (2.53 × 108  copies) 
of a pure plasmid DNA, pRSET-NS1 (unpublished data), 
was performed to construct a 5-point standard curve. The 
forward primer (5’- AAG GAT CAT AGC TCG AGA GAT 
TCC AAC ACT GTG -3’) and reverse primers (5’- GCA 
GTT TTC GAA TTC AAC TTC TGA CTC AAT -3’) were 
used for the amplification of the standard. Thermal cycling 
was performed in the Step One Plus systems (Applied 
Biosystems, California, USA) with PCR cycling conditions: 
90°C for 2 min, 40 cycles of 95°C for 30 s, 40 cycles 
of 60°C for 30 s and 72°C for 1 min. The primer-dimer 
melting step was included to monitor the amplification 
of the products. Gene copies of the test samples were 
calculated as gene copies/μL based on the standard curve 
and reported as log10 values.
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STATISTICAL ANALYSIS
Data analysis was conducted with Statistics Package for 
Social Sciences (SPSS) version 20.0. Independent sample t 
test was used to examine the significance of CPE percentage 
between infected and uninfected cell. Spearman’s (rho) 
correlation was used to assess the relationship between 
CPE percentage and the viral load in samples. 
RESULTS
MEASUREMENT OF VIRUS INFECTIVITY
The TCID50 was calculated based on the Reed-Muench 
method (Reed & Muench 1938). The TCID50 of AIV H5N1 
for MDCK and Vero cells were 105.67/mL and 103.5/mL, 
respectively. Meanwhile, the MOI of AIV H5N1 in MDCK cell 
was 0.944 while in Vero cell was 0.157. The nearly 100-
fold higher TCID50 value and nearly six-fold higher MOI 
value in MDCK cell indicates a higher viral titer production 
in the cell line compared to that by the Vero cell.
ASSESSMENT OF CPE PERCENTAGE
The replication of the AIV H5N1 was observed by assessing 
the CPE percentage in MDCK and Vero cells. As shown 
in Figure 1, both MDCK and Vero cells started to exhibit 
significant CPE after 48 h p.i (p < 0.05). MDCK cells appeared 
to be more susceptible to the virus infection than Vero cells 
throughout the viral incubation period. The CPE percentage, 
for MDCK and Vero cells, peaked at 90.55±1.00% and 
80.48±0.34%, respectively, after 120 h p.i.
REAL TIME PCR
The primers specificity was verified in a melting curve 
analysis (data not shown). There was no noticeable 
amplification in negative control and non-template control 
samples. The viral loads of AIV H5N1 in MDCK and Vero 
cells were measured by absolute quantification of the target 
gene, M2 in the virus-infected culturing media and cells. It 
was found that the CPE percentage correlated positively and 
significantly with the viral load in the infected MDCK cells 
(rho = 0.674, p < 0.001) (Figure 2(a)) and Vero cells (rho = 
0.925, p < 0.001) (Figure 2(b)). As shown in Figure 3, the 
viral load in the MDCK culturing media was higher than that 
of Vero throughout the incubation period, with 6.37±0.009 
and 6.31±0.074 log10 gene copies/μL, respectively at 120 
h p.i.  However, the similar trend was not observed in the 
cells. The viral load in MDCK cells increased drastically 
after 12 h p.i and peaked at 48 h p.i with 7.08±0.025 
log10 gene copies/μL. In the later time points, the viral 
load in MDCK cells showed a gradual decreasing trend 
and finally declined to 5.90±0.009 log10 gene copies/μL 
at 120 h p.i. Whereas in Vero cells, the increase in viral 
load was rather constant although slower. It continued to 
increase throughout 120 h p.i where the viral load peaked 
at 7.36±0.031 log10 gene copies/μL. By comparing the 
viral load in culturing media and infected cells, it was 
found that the viral loads in MDCK and Vero cells were 
significantly higher than in the culturing media. In MDCK 
samples, the viral load measured at 120 h p.i appeared to 
be slightly higher in the culturing media (6.37±0.009 log10 
gene copies/μL) than that present in the cells (5.09±0.009 
log10 gene copies/μL). Overall, the findings imply that a 
FIGURE 1. CPE percentage of infected and uninfected (negative control) MDCK and Vero cells. The data 
are reported in mean value ± SEM (n=3). The symbol  indicates statistically significant (p < 0.05) whereas 
indicates statistically very significant (p < 0.001) compared to the negative control
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faster virus replication is taking place in MDCK cells than 
that in Vero cells. 
DISCUSSION
Substitution of the egg-based system by the cell culture 
approach for inactivated or attenuated influenza vaccine 
production has raised the question of which cell line 
is more suitable for virus cultivation. Theoretically, a 
higher virus titer produced in a cell line represents a 
larger scale of vaccine production is permitted by the 
particular cell line. Hence, this study aimed to compare 
the replication of a Malaysian strain AIV H5N1 in MDCK 
and Vero cell lines. The CPE exerted by the AIV H5N1 
infection on the host cells and also the viral loads formed 
in the host cells and culturing media were evaluated at 
designated time points. MDCK and Vero cell lines were 
selected for virus replication in this study because they 
are recognized widely and are recommended by the World 
Health Organization (WHO) for the propagation of various 
influenza viruses (WHO 2005).
 First and foremost, TCID50 and MOI of the AIV H5N1 
virus seed used in the study were determined. It was found 
that higher TCID50 and MOI values of AIV H5N1 were 
achieved by propagating the virus in MDCK cells than in 
Vero cells. The higher TCID50 and MOI values obtained 
from the MDCK samples suggest that the MDCK cell line 
could be a better cell-based system to produce AIV H5N1. 
In this light, a more reliable and sensitive quantification 
approach, real-time PCR was employed to measure the viral 
load in MDCK and Vero cells.
 In order to ensure that the AIV H5N1 was provided 
with sufficient host cells for infection, the MDCK and Vero 
cells were infected with a relatively low virus titer at MOI 
0.1. Both of the cell lines began to exhibit significant CPE, 
particularly cell death after 48 h p.i. The infected MDCK 
FIGURE 2. Correlation of viral load and CPE percentage in infected cells. The data are reported 
in mean value ± SEM (n=3). (A) The viral load in infected MDCK cells correlated positively and 
significantly with CPE (rho = 0. 674, p < 0.001). (B) The viral load in infected Vero cells correlated 
positively and significantly with CPE (rho = 0.925, p < 0.001)
(a)
(b)
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cells appeared to be more vulnerable to the virus infection 
compared to Vero cells throughout the incubation period. 
This observation parallels several previous studies in 
which MDCK cells were shown to be highly susceptible 
to influenza virus compared to the other host cell types 
(Lugovtsev et al. 2013; Seitz et al. 2010). The higher 
percentage of cell death could also be explained by a higher 
viral load produced in MDCK cells at early time points of 
infection.
 The level of viral load in patients has been demonstrated 
as one of the important indicators in influenza H5N1 
pathogenesis (De Jong et al. 2006; Lau et al. 2010). The 
amount of virus that is present early in the course of 
infection reflects its direct CPE on host cells (El Saleeby et 
al. 2011). Generally, in this study, it was shown that the CPE 
percentage correlated positively and significantly with the 
viral load in both MDCK and Vero cells. In later time points, 
a gradual decline in the viral load was observed after 48 h 
p.i in MDCK cell. However, the CPE percentage continued 
to soar. Permissive host cells are important biological 
machinery for the production of virus particles (Whittaker 
2001).  Hence, the scarcity of viable cells due to high CPE 
in the later time points could account for reduction in the 
viral load produced in MDCK cells whereas in Vero cells, 
the CPE percentage and the viral load increased consistently 
but at a slower rate.
 By comparing the culturing media of MDCK to that of 
Vero, a higher viral load was observed in MDCK culturing 
media throughout the incubation period. However, the 
maximum viral load measured in culturing media for 
both cell lines after 120 h p.i was almost identical (~6.30 
log10 gene copies/μL). In infected host cells, a more rapid 
viral replication was observed in MDCK cells compared to 
Vero cells. The maximum viral load was achieved within 
48 h p.i in MDCK cells whereas the maximum viral load 
was achieved later in Vero cell at 120 h p.i. The similar 
phenomenon was also observed in a number of previous 
studies (Govorkova et al. 1995; Youil et al. 2004). Overall, 
both of the cell lines have been proven to be capable of 
permitting efficient AIV H5N1 replication.
 When analyzing the distribution of AIV H5N1 in 
the infected media and host cells, a higher viral load 
was detected in MDCK and Vero cells compared to their 
respective culturing media. This finding further ascertains a 
similar observation in a previous study which demonstrated 
the inefficiency of influenza viral shedding (Nayak et al. 
2009). The virus particles were found not to be released 
readily from the host cells into the surrounding during 
the virus replication. However, the viral load in culturing 
media, albeit lower than that in host cell, is still remarkably 
important in producing influenza virions. Interestingly, a 
smaller viral load difference was detected between the 
host cells and culturing media at the later time points of 
infection. This scenario could be attributed to the release of 
more virus particles from the cells into the culturing media 
at the later time point, which is mostly due to apoptosis 
(Hinshaw et al. 1994). The accumulated infectious particles 
could not carry out further infection because more than 
90% of the infected cells had died. In view of this, the viral 
load in the MDCK culturing media was therefore slightly 
higher than that in the infected MDCK cells after 120 h p.i.
CONCLUSION
In conclusion, both MDCK and Vero cell lines support 
efficient AIV H5N1 replication. Even though the maximum 
FIGURE 3. Comparison of AIV H5N1 viral load in the infected cells and their respective 
culturing media. The data are reported in mean value ± SEM (n=3)
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viral load achieved in both cell lines did not seem to differ 
significantly, a more rapid replication was observed in 
infected MDCK host cell. This study suggests a more time-
saving and hence cost-effective MDCK cell based influenza 
vaccine production. 
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